Product Program year 2025 Source: CMS Open Payments

FFR Link

Device FFR Link_IC

PDI 08714729890010

Open in the dashboard

General payments

$13,152

194 payments

Research payments

$0

0 payments

Through program year 2025, $13,152 in general payments and $0 in research payments were reported against FFR Link (FFR Link_IC).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $717 39
2024 General $4,147 46
2023 General $1,789 67
2022 General $817 33
2021 General $5,682 9

Breakdown

Who paid General payments · program years 2021–2025
  1. Boston Scientific Corporation $13,152 194 payments
Top recipients General payments · program year 2025
  1. Daniel Steinberg Interventional Cardiology · Charleston, SC $94 13% · 1 payment
  2. Parag Patel Cardiovascular Disease · Bridgewater, NJ $44 6% · 1 payment
  3. Sharan Mahal Cardiovascular Disease · Bridgewater, NJ $44 6% · 1 payment
  4. Jay Shah Interventional Pain Medicine · Colonia, NJ $44 6% · 1 payment
  5. Harsh Doshi Cardiovascular Disease · Plainfield, NJ $37 5% · 1 payment

The top 5 of 35 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Interventional Cardiology Internal Medicine $199 28% · 10 practitioners
  2. Cardiovascular Disease Internal Medicine $195 27% · 8 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $91 13% · 4 practitioners
  4. Interventional Pain Medicine Pain Medicine $44 6% · 1 practitioner
  5. Nurse Practitioner, Acute Care Nurse Practitioner $41 6% · 3 practitioners

The top 5 of 12 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New Jersey $225 31% · 7 recipients
  2. New York $157 22% · 7 recipients
  3. South Carolina $94 13% · 1 recipient
  4. Texas $58 8% · 4 recipients
  5. Louisiana $57 8% · 2 recipients

The top 5 of 13 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

194 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record